Actelion Ltd.
is a leading
biopharmaceutical
company focused
on the discovery,
development
and commercialization
of innovative drugs
for diseases
with significant
unmet medical needs.

Actelion advances development of its specialty immunology pipeline

Jean-Paul Clozel, CEO “Our efforts in the
field of immunology have reached
the necessary maturity to warrant
fully-fledged clinical investigation.”

Jean-Paul Clozel, CEO “Our efforts in the
field of immunology have reached
the necessary maturity to warrant
fully-fledged clinical investigation.”

Global Actelion

Hotspot of possibilities

Actelion has subsidaries in over 30 countries, covering all major pharmaceutical markets worldwide

Hotspot of possibilities

Actelion has subsidaries in over 30 countries, covering all major pharmaceutical markets worldwide

Shareprice

ATLN SIX Swiss Exchange

Shareprice
At 17:31:08 CET 20/04/2015
CHF 116,90Up Down image
+1,80 (+1,56%)